Principles of Antimicrobial Therapy — MCQs
Which antibiotic acts by inhibiting protein synthesis?
Which of the following is the drug of choice for preoperative antibiotic prophylaxis in a patient undergoing cardiac surgery?
A postoperative patient developed septicemia and was empirically started on combination chemotherapy by a new resident doctor. However, when the patient did not respond even after 10 days of antibiotic treatment, the review of the charts was done. It was found that the resident doctor had started the combination of antibiotics that was mutually antagonistic in action. Which of the following is the most likely combination that was given?
A diabetic patient developed cellulitis due to S. aureus, which was found to be methicillin resistant on the antibiotic sensitivity testing. All of the following antibiotics will be appropriate except ?
Continued suppression of bacterial growth after antibiotic levels have fallen below the Minimum Inhibitory Concentration (MIC) is known as?
Which antimicrobial inhibits cell wall synthesis?
Persistent suppression of microbial growth below MIC is known as:
What should you do next for a 35-year-old man who is positive for HBsAg and HBeAg, discovered incidentally during blood donation screening, with normal SGOT and SGPT laboratory values?
A 25-year-old man with 3 weeks of fever presented with tricuspid valve vegetation. The patient is an intravenous drug abuser. The most common cause of endocarditis in this patient is:
A 30-year-old male is found to be positive for HBsAg and HBeAg and is diagnosed with chronic hepatitis B. The patient's viral load is 2 × 10^5 IU/mL and ALT is elevated (2× upper limit of normal). What is the appropriate management in this patient?
Principles of Antimicrobial Therapy Indian Medical PG Practice Questions and MCQs
Question 1: Which antibiotic acts by inhibiting protein synthesis?
- A. Cefotetan
- B. Doxycycline (Correct Answer)
- C. Ciprofloxacin
- D. Oxacillin
Explanation: ***Doxycycline*** - **Doxycycline** is a **tetracycline antibiotic** that inhibits bacterial protein synthesis by binding reversibly to the **30S ribosomal subunit**, preventing the attachment of aminoacyl-tRNA. - This action effectively blocks the elongation of the peptide chain, halting bacterial growth. *Cefotetan* - **Cefotetan** is a **second-generation cephalosporin** that inhibits bacterial cell wall synthesis. - It does this by binding to and inactivating **penicillin-binding proteins (PBPs)**, which are essential for peptidoglycan cross-linking. *Ciprofloxacin* - **Ciprofloxacin** is a **fluoroquinolone antibiotic** that inhibits bacterial **DNA synthesis**. - It targets **DNA gyrase (topoisomerase II)** and **topoisomerase IV**, enzymes crucial for DNA replication, transcription, and repair. *Oxacillin* - **Oxacillin** is a **beta-lactam antibiotic** (specifically a penicillinase-resistant penicillin) that, like cephalosporins, inhibits bacterial **cell wall synthesis**. - It achieves this by binding to and inactivating **penicillin-binding proteins (PBPs)**, thereby interfering with peptidoglycan cross-linking.
Question 2: Which of the following is the drug of choice for preoperative antibiotic prophylaxis in a patient undergoing cardiac surgery?
- A. Cefazolin (Correct Answer)
- B. Penicillin
- C. Clindamycin
- D. Vancomycin
Explanation: ***Cefazolin*** - **Cefazolin** is a first-generation cephalosporin that provides excellent coverage against **Staphylococcus aureus** and **Streptococcus species**, which are common pathogens in surgical site infections in cardiac surgery. - It has a favorable safety profile, long half-life allowing for convenient dosing, and good tissue penetration, making it the preferred choice for **preoperative antibiotic prophylaxis** in most cardiac surgery cases. *Penicillin* - **Penicillin** has a narrow spectrum of activity compared to cefazolin and does not adequately cover all potential pathogens in cardiac surgery, particularly **methicillin-susceptible Staphylococcus aureus (MSSA)**. - Due to its limited spectrum, penicillin is generally not recommended for routine **surgical prophylaxis**, especially in complex procedures like cardiac surgery. *Clindamycin* - **Clindamycin** is an alternative for patients with **beta-lactam allergies**, providing coverage against gram-positive organisms and anaerobes. - However, for routine prophylaxis without a specific allergy or high risk of resistant organisms, **clindamycin** is less effective than cefazolin against the most prevalent surgical pathogens. *Vancomycin* - **Vancomycin** is reserved for patients with a known **penicillin allergy** or a high risk of **methicillin-resistant Staphylococcus aureus (MRSA)** colonization or infection. - Its routine use as a primary prophylactic agent in cardiac surgery is discouraged to prevent the development of **vancomycin resistance**.
Question 3: A postoperative patient developed septicemia and was empirically started on combination chemotherapy by a new resident doctor. However, when the patient did not respond even after 10 days of antibiotic treatment, the review of the charts was done. It was found that the resident doctor had started the combination of antibiotics that was mutually antagonistic in action. Which of the following is the most likely combination that was given?
- A. Vancomycin and Amikacin
- B. Cephalexin and Gentamicin
- C. Ampicillin and Chloramphenicol (Correct Answer)
- D. Ciprofloxacin and Piperacillin
Explanation: ***Ampicillin and Chloramphenicol*** - **Ampicillin** is a **bactericidal** antibiotic that inhibits cell wall synthesis, while **chloramphenicol** is **bacteriostatic** and inhibits protein synthesis. - When combined, the bacteriostatic action of chloramphenicol can antagonize the antimicrobial effect of ampicillin, particularly in infections where rapid bacterial killing is crucial. *Vancomycin and Amikacin* - **Vancomycin** is **bactericidal** (cell wall synthesis inhibitor), and **amikacin** is also **bactericidal** (aminoglycoside, protein synthesis inhibitor). - This combination is generally considered synergistic or additive, especially against gram-positive organisms and certain gram-negative bacteria, rather than antagonistic. *Cephalexin and Gentamicin* - Both **cephalexin** (a cephalosporin) and **gentamicin** (an aminoglycoside) are **bactericidal** antibiotics. - This combination can be synergistic, particularly against gram-negative bacteria, by targeting different bacterial processes (cell wall synthesis and protein synthesis, respectively). *Ciprofloxacin and Piperacillin* - **Ciprofloxacin** (a fluoroquinolone) and **piperacillin** (a penicillin) are both **bactericidal** antibiotics. - This combination is often used empirically to broaden coverage against a wide range of bacteria, exhibiting additive or synergistic effects, and is not typically antagonistic.
Question 4: A diabetic patient developed cellulitis due to S. aureus, which was found to be methicillin resistant on the antibiotic sensitivity testing. All of the following antibiotics will be appropriate except ?
- A. Vancomycin
- B. Teicoplanin
- C. Linezolid
- D. Imipenem (Correct Answer)
Explanation: ***Imipenem*** - **Imipenem** is a carbapenem antibiotic that is effective against many Gram-positive and Gram-negative bacteria, but it is **not active against MRSA (methicillin-resistant *Staphylococcus aureus*)**. - MRSA strains are resistant to all beta-lactam antibiotics, including penicillins, cephalosporins, and carbapenems like imipenem, due to the presence of the **mecA gene** which encodes for an altered penicillin-binding protein (PBP2a). *Vancomycin* - **Vancomycin** is a glycopeptide antibiotic that is a primary choice for treating **MRSA infections**, including cellulitis. - It inhibits cell wall synthesis by binding to the D-Ala-D-Ala precursor, preventing cross-linking, and is specifically active against **Gram-positive bacteria**. *Teicoplanin* - **Teicoplanin** is another glycopeptide antibiotic, similar to vancomycin, and is also considered a suitable agent for treating **MRSA infections**. - It works by inhibiting bacterial cell wall synthesis and has a **longer half-life** than vancomycin, allowing for less frequent dosing. *Linezolid* - **Linezolid** is an oxazolidinone antibiotic known for its activity against **Gram-positive bacteria**, including **MRSA** and vancomycin-resistant enterococci (VRE). - It inhibits protein synthesis by binding to the 50S ribosomal subunit, preventing the formation of the initiation complex.
Question 5: Continued suppression of bacterial growth after antibiotic levels have fallen below the Minimum Inhibitory Concentration (MIC) is known as?
- A. Time dependent killing
- B. Sequential blockade
- C. Concentration dependent killing
- D. Post antibiotic effect (Correct Answer)
Explanation: ***Post antibiotic effect*** - The **post-antibiotic effect (PAE)** refers to the continued suppression of bacterial growth after antibiotic levels have fallen below the **Minimum Inhibitory Concentration (MIC)**. - This phenomenon allows for less frequent dosing while maintaining efficacy, which is important for drug scheduling. *Time dependent killing* - **Time-dependent killing** means that the duration for which the antibiotic concentration stays above the **MIC** is the most important factor for efficacy, not necessarily the peak concentration. - Antibiotics with this characteristic, such as **beta-lactams**, often require frequent dosing or continuous infusion. *Sequential blockade* - **Sequential blockade** occurs when two drugs act on consecutive steps in a metabolic pathway, leading to a synergistic effect that results in enhanced microbial killing. - A classic example is the combination of **sulfamethoxazole and trimethoprim**, which inhibit different enzymes in the folic acid synthesis pathway. *Concentration dependent killing* - **Concentration-dependent killing** indicates that the rate and extent of bacterial killing increase as the antibiotic concentration rises, particularly when it exceeds the **MIC**. - Antibiotics like **aminoglycosides** exhibit this effect, often benefiting from high peak concentrations to maximize efficacy.
Question 6: Which antimicrobial inhibits cell wall synthesis?
- A. Metronidazole
- B. Azithromycin
- C. Vancomycin (Correct Answer)
- D. Ciprofloxacin
Explanation: ***Vancomycin*** - **Vancomycin** is a glycopeptide antibiotic that inhibits cell wall synthesis by binding to the **D-Ala-D-Ala** terminal of peptidoglycan precursors. - This binding prevents the **transpeptidation** and **transglycosylation** steps necessary for peptidoglycan chain elongation and cross-linking, ultimately weakening the bacterial cell wall and leading to bacterial lysis. *Metronidazole* - **Metronidazole** is an antimicrobial that works by forming **toxic free-radical metabolites** that damage bacterial **DNA**. - Its mechanism of action does not involve direct inhibition of cell wall synthesis. *Azithromycin* - **Azithromycin** is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the **50S ribosomal subunit**. - This binding prevents **peptide chain elongation**, thereby halting protein production, rather than affecting the cell wall. *Ciprofloxacin* - **Ciprofloxacin** is a fluoroquinolone antibiotic that inhibits bacterial **DNA replication** and repair. - It achieves this by targeting **DNA gyrase** (topoisomerase II) and **topoisomerase IV**, enzymes crucial for bacterial DNA handling, and thus does not act on the cell wall.
Question 7: Persistent suppression of microbial growth below MIC is known as:
- A. Paradoxical effect
- B. Post antibiotic effect (Correct Answer)
- C. Adverse effect
- D. Post exposure prophylaxis
Explanation: ***Post antibiotic effect*** - This phenomenon refers to the continued **suppression of bacterial growth** even after the antibiotic concentration has fallen below the **minimum inhibitory concentration (MIC)**. - It allows for less frequent dosing intervals without compromising efficacy. - Clinically important for **aminoglycosides and fluoroquinolones**, which exhibit significant PAE. *Paradoxical effect* - The **paradoxical effect** (or Eagle effect) refers to the phenomenon where certain antibiotics, particularly penicillin, become *less effective* at very high concentrations. - This effect is not about persistent suppression below MIC, but rather a **decreased bactericidal activity** at concentrations far exceeding MIC. *Post exposure prophylaxis* - **Post exposure prophylaxis (PEP)** refers to preventive treatment given after exposure to an infectious agent (e.g., HIV PEP, rabies PEP). - This is a clinical intervention strategy, not a pharmacodynamic phenomenon describing antibiotic behavior below MIC. *Adverse effect* - An **adverse effect** refers to an unintended and undesirable reaction to a drug, which is not relevant to the described microbial growth suppression. - This term describes harmful side effects experienced by the patient, not a microbiological phenomenon.
Question 8: What should you do next for a 35-year-old man who is positive for HBsAg and HBeAg, discovered incidentally during blood donation screening, with normal SGOT and SGPT laboratory values?
- A. HBV-DNA estimation (Correct Answer)
- B. Observation
- C. Liver biopsy
- D. Interferon therapy
Explanation: ***HBV-DNA estimation*** - The presence of **HBsAg** and **HBeAg** indicates **active viral replication**, necessitating quantification of HBV-DNA to assess viral load [1]. - Normal SGOT and SGPT suggest compensated liver function, but **viral load** is crucial for staging the disease and guiding future management [1]. *Observation* - While liver enzymes are normal, the presence of **HBsAg** and **HBeAg** indicates active hepatitis B infection, which warrants further investigation, not just observation [1]. - Undiagnosed and untreated chronic hepatitis B can lead to serious complications such as **cirrhosis** and **hepatocellular carcinoma** [1]. *Liver biopsy* - **Liver biopsy** is an invasive procedure typically reserved for cases where histological assessment is required to confirm **fibrosis** or **inflammation severity**, or when there's discordance between viral markers and clinical presentation. - It's not the initial step for a patient with normal transaminases and clear serological markers of active infection; **HBV-DNA estimation** is generally performed first [1]. *Interferon therapy* - **Interferon therapy** is a treatment for chronic hepatitis B, but initiating treatment requires a comprehensive assessment including **HBV-DNA levels**, in addition to liver enzyme levels and evaluation of liver damage [2]. - It would be premature to consider treatment without a **viral load** measurement and a full workup to determine the phase of infection and the need for therapy [2].
Question 9: A 25-year-old man with 3 weeks of fever presented with tricuspid valve vegetation. The patient is an intravenous drug abuser. The most common cause of endocarditis in this patient is:
- A. Strep. viridans
- B. Pseudomonas
- C. Candida albicans
- D. Staph. aureus (Correct Answer)
Explanation: ***Staph. aureus*** - **Intravenous drug abuse (IVDA)** is a major risk factor for infective endocarditis, and *Staphylococcus aureus* is the most common causative organism, [1] particularly affecting the **tricuspid valve** on the right side of the heart. [2] - *S. aureus* can colonize the skin and needles used in IVDA, directly introducing bacteria into the bloodstream and to the heart valves. [1][3] *Strep. viridans* - *Streptococcus viridans* (viridans streptococci) is a common cause of native valve endocarditis, often following **dental procedures** or due to poor dental hygiene. [1] - It typically affects the **left-sided heart valves** (mitral or aortic) rather than the tricuspid valve, and is less commonly associated with IVDA. *Pseudomonas* - *Pseudomonas aeruginosa* can cause endocarditis, especially in IVDA patients or those with prosthetic valves, but it is **less common** than *Staphylococcus aureus* in this population. - While possible, it's not the *most common* cause specified in the question. *Candida albicans* - *Candida albicans* endocarditis is largely associated with **immunocompromised patients**, those with prosthetic valves, or prolonged use of broad-spectrum antibiotics, [4] not typically healthy IV drug abusers. - Fungal endocarditis is generally **rare** compared to bacterial endocarditis.
Question 10: A 30-year-old male is found to be positive for HBsAg and HBeAg and is diagnosed with chronic hepatitis B. The patient's viral load is 2 × 10^5 IU/mL and ALT is elevated (2× upper limit of normal). What is the appropriate management in this patient?
- A. Combined pegylated interferon with lamivudine
- B. Pegylated interferon
- C. Lamivudine
- D. Tenofovir (Correct Answer)
Explanation: Tenofovir - This patient presents with chronic hepatitis B (HBsAg positive for >6 months), evidence of active viral replication (HBeAg positive, high viral load), and liver inflammation (elevated ALT). [3] This signifies chronic active hepatitis B, requiring treatment. [1] - Tenofovir is a highly potent nucleotide analog with a high barrier to resistance, making it a first-line treatment for chronic hepatitis B. *Lamivudine* - While an antiviral for HBV, lamivudine has a low genetic barrier to resistance, meaning resistance mutations can rapidly develop, reducing its long-term efficacy. - Due to the high risk of resistance, lamivudine is generally not recommended as a first-line monotherapy for treatment-naive patients with chronic hepatitis B, especially with a high viral load. *Pegylated interferon* - Pegylated interferon is an option for chronic hepatitis B, but it causes significant side effects (e.g., fatigue, depression, bone marrow suppression) and is usually administered by injection. [2] - Its efficacy in achieving sustained HBeAg seroconversion or HBsAg loss can be variable, and it is often reserved for patients who prefer a finite course of treatment and can tolerate the side effects, or for those without advanced liver disease. [2] *Combined pegylated interferon with lamivudine* - There is no significant evidence that combining pegylated interferon with lamivudine offers superior efficacy compared to monotherapy with a potent nucleos(t)ide analog like tenofovir or entecavir. - This combination would increase the side effect burden from interferon and still carry the risk of lamivudine resistance without substantial added benefit.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free